| Production and Deliveries | ||
•19,751 vehicles produced at Rivian’s manufacturing facility in Normal, Illinois. | ||
•19,248 vehicles delivered to customers. | ||
| Revenues | ||
•Consolidated revenue was $2.155 billion, a 38 percent increase over the same quarter of the prior year. This was driven by a 46 percent year-over-year increase in delivery volumes, $81 million in revenues related to regulatory credits, and strong performance from the company’s software and services segment. | ||
◦Automotive revenue was $1.550 billion, a 36 percent increase over the same quarter of the prior year, primarily due to the increase in vehicle deliveries and an $80 million increase in revenues related to regulatory credits, which were partially offset by a decline in average vehicle selling price due to a higher mix of R2 and commercial van deliveries. | ||
◦Software and services revenue was $605 million, a 45 percent increase over the same quarter of the prior year, primarily due to increases in vehicle electrical architecture and software development services, vehicle repair and maintenance services, and Autonomy+, partially offset by lower remarketing sales. $354 million or 59 percent of software and services revenue was attributable to the company’s joint venture with Volkswagen Group. | ||
| Gross Profit | ||
•Consolidated gross profit was $176 million, a $152 million improvement over the same quarter of the prior year. | ||
◦Automotive gross profit loss for the third quarter was $(80) million compared to $(130) million in the same quarter of the prior year, a $50 million improvement primarily resulting from increases in delivery volumes at an improved per unit margin, an increase in revenues related to regulatory credits, and an IEEPA tariff refund receivable, partially offset by costs related to the ramp of R2 production. In the quarter, Rivian recognized approximately $120 million in incremental cost of revenues due to the ramp of R2 production as compared to production at more normalized levels. | ||
◦Software and services gross profit for the third quarter was $256 million, a 42 percent margin and $102 million improvement over the same quarter of the prior year at $154 million, primarily due to increases in vehicle electrical architecture and software development services from the joint venture with Volkswagen Group and Autonomy+. | ||
| Operating Expenses and Operating Loss | ||
•Total operating expenses in the third quarter increased to $1.057 billion compared to $1.007 billion in the same quarter of the prior year. | ||
◦Research and development (R&D) expenses were $485 million compared to $453 million in the same quarter of the prior year. The increase was primarily driven by increases in software expenses to support AI and autonomy initiatives, partially offset by a reduction in engineering, design, and development spend. | ||
◦Selling, general and administrative (SG&A) expenses remained relatively consistent at $572 million compared to $554 million in the same quarter of the prior year. | ||
•For the third quarter, the company experienced a loss from operations of $(881) million compared to $(983) million in the same quarter of the prior year, a $102 million improvement. | ||
| Adjusted Operating Expenses (non-GAAP) | ||
•Total adjusted operating expenses for the third quarter were $799 million compared to $783 million for the same quarter of the prior year. | ||
◦Adjusted R&D expenses for the third quarter were $382 million compared to $361 million for the same quarter of the prior year. | ||
◦Adjusted SG&A expenses for the third quarter were $417 million compared to $422 million for the same quarter of the prior year. | ||
| Net Loss | ||
•Net loss attributable to common stockholders for the third quarter was $(913) million compared to $(1.173) billion for the same quarter of the prior year. | ||
| Adjusted EBITDA (non-GAAP) | ||
•Adjusted EBITDA for the third quarter was $(435) million compared to $(602) million for the same quarter of the prior year. | ||
| Net Cash Used in Operating Activities | ||
•Net cash (used in) provided by operating activities for the third quarter was $(758) million, compared to $26 million for the same quarter of the prior year, primarily driven by a change in cash used by working capital. Cash used by working capital for the third quarter of 2026 was primarily driven by a reduction in deferred revenues and a buildup of inventory purchases to support the launch of R2. | ||
| Adjusted Net Loss Per Share | ||
•Adjusted net loss per share for the third quarter was $(0.48) compared to $(0.65) for the same quarter of the prior year. | ||
| Capital Expenditures | ||
•Capital expenditures for the third quarter were $(366) million, compared to $(447) million for the same quarter of the prior year. | ||
| Liquidity and Free Cash Flow (non-GAAP) | ||
•Rivian ended the third quarter with $5.502 billion in cash, cash equivalents, and short-term investments. | ||
◦Including the capacity under its asset-based revolving-credit facility, the company ended the third quarter with $6.095 billion of total liquidity, which, with the pro forma addition of $1.000 billion received in October 2026 from the non-recourse 10-year term loan facility from Volkswagen Group, would be total available liquidity of $7.095 billion. | ||
•Rivian defines free cash flow as net cash used in operating activities less capital expenditures. The net cash used by operating activities in the third quarter partially offset by the decrease in capital expenditures identified above resulted in free cash flow of $(1,124) million compared to $(421) million for the same quarter of the prior year. | ||
| Current Outlook | |||||
| Vehicles Delivered | 67,000 – 70,000 | ||||
| Adjusted EBITDA | $(1.85)B – $(1.75)B | ||||
| Capital Expenditures | $1.40B – $1.50B | ||||
| Quarterly Financial Performance | ||||||||||||||
(in millions, except production, delivery, and gross margin) | ||||||||||||||
(unaudited) | ||||||||||||||
| Three Months Ended | ||||||||||||||||||||||||||||||||
| September 30, 2025 | December 31, 2025 | March 31, 2026 | June 30, 2026 | September 30, 2026 | ||||||||||||||||||||||||||||
| Production | 10,720 | 10,974 | 10,236 | 12,613 | 19,751 | |||||||||||||||||||||||||||
| Delivery | 13,201 | 9,745 | 10,365 | 12,194 | 19,248 | |||||||||||||||||||||||||||
| Revenues | ||||||||||||||||||||||||||||||||
| Automotive | $ | 1,142 | $ | 839 | $ | 908 | $ | 1,143 | $ | 1,550 | ||||||||||||||||||||||
| Software and services | 416 | 447 | 473 | 515 | 605 | |||||||||||||||||||||||||||
| Total revenues | $ | 1,558 | $ | 1,286 | $ | 1,381 | $ | 1,658 | $ | 2,155 | ||||||||||||||||||||||
| Cost of revenues | ||||||||||||||||||||||||||||||||
| Automotive | $ | 1,272 | $ | 898 | $ | 970 | $ | 1,179 | $ | 1,630 | ||||||||||||||||||||||
| Software and services | 262 | 268 | 292 | 300 | 349 | |||||||||||||||||||||||||||
| Total cost of revenues | $ | 1,534 | $ | 1,166 | $ | 1,262 | $ | 1,479 | $ | 1,979 | ||||||||||||||||||||||
| Gross profit | $ | 24 | $ | 120 | $ | 119 | $ | 179 | $ | 176 | ||||||||||||||||||||||
| Gross margin | 2 | % | 9 | % | 9 | % | 11 | % | 8 | % | ||||||||||||||||||||||
| Research and development | $ | 453 | $ | 424 | $ | 458 | $ | 466 | $ | 485 | ||||||||||||||||||||||
| Selling, general, and administrative | 554 | 529 | 542 | 549 | 572 | |||||||||||||||||||||||||||
| Total operating expenses | $ | 1,007 | $ | 953 | $ | 1,000 | $ | 1,015 | $ | 1,057 | ||||||||||||||||||||||
| Adjusted research and development (non-GAAP)¹ | $ | 361 | $ | 328 | $ | 348 | $ | 347 | $ | 382 | ||||||||||||||||||||||
| Adjusted selling, general, and administrative (non-GAAP)¹ | 422 | 384 | 392 | 384 | 417 | |||||||||||||||||||||||||||
| Total adjusted operating expenses (non-GAAP)¹ | $ | 783 | $ | 712 | $ | 740 | $ | 731 | $ | 799 | ||||||||||||||||||||||
Adjusted EBITDA (non-GAAP)1 | $ | (602) | $ | (465) | $ | (472) | $ | (379) | $ | (435) | ||||||||||||||||||||||
| Cash, cash equivalents, and short-term investments | $ | 7,088 | $ | 6,082 | $ | 4,830 | $ | 5,310 | $ | 5,502 | ||||||||||||||||||||||
| Net cash provided by (used in) operating activities | $ | 26 | $ | (681) | $ | (703) | $ | (487) | $ | (758) | ||||||||||||||||||||||
| Capital expenditures | (447) | (463) | (372) | (362) | (366) | |||||||||||||||||||||||||||
Free cash flow (non-GAAP)1 | $ | (421) | $ | (1,144) | $ | (1,075) | $ | (849) | $ | (1,124) | ||||||||||||||||||||||
| Depreciation and amortization expense | ||||||||||||||||||||||||||||||||
| Cost of revenues | $ | 125 | $ | 108 | $ | 122 | $ | 138 | $ | 166 | ||||||||||||||||||||||
| Research and development | 18 | 20 | 23 | 25 | 24 | |||||||||||||||||||||||||||
| Selling, general, and administrative | 55 | 59 | 57 | 64 | 61 | |||||||||||||||||||||||||||
| Total depreciation and amortization expense | $ | 198 | $ | 187 | $ | 202 | $ | 227 | $ | 251 | ||||||||||||||||||||||
| Stock-based compensation expense | ||||||||||||||||||||||||||||||||
| Cost of revenues | $ | 24 | $ | 26 | $ | 27 | $ | 31 | $ | 28 | ||||||||||||||||||||||
| Research and development | 74 | 76 | 87 | 94 | 79 | |||||||||||||||||||||||||||
| Selling, general, and administrative | 77 | 86 | 93 | 101 | 94 | |||||||||||||||||||||||||||
| Total stock-based compensation expense | $ | 175 | $ | 188 | $ | 207 | $ | 226 | $ | 201 | ||||||||||||||||||||||
| ¹A reconciliation of non-GAAP financial measures to the most comparable GAAP measure is provided later in this presentation. | ||||||||||||||||||||||||||||||||
Condensed Consolidated Balance Sheets1 | ||||||||||||||
(in millions, except per share amounts) | ||||||||||||||
(unaudited) | ||||||||||||||
| Assets | December 31, 2025 | September 30, 2026 | ||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 3,579 | $ | 3,509 | ||||||||||
| Short-term investments | 2,503 | 1,993 | ||||||||||||
| Accounts receivable, net | 555 | 596 | ||||||||||||
| Inventory | 1,594 | 1,779 | ||||||||||||
| Other current assets | 361 | 259 | ||||||||||||
| Total current assets | 8,592 | 8,136 | ||||||||||||
| Property, plant, and equipment, net | 5,119 | 5,605 | ||||||||||||
| Operating lease assets, net | 571 | 778 | ||||||||||||
| Strategic investments | 119 | 682 | ||||||||||||
| Other non-current assets | 463 | 526 | ||||||||||||
| Total assets | $ | 14,864 | $ | 15,727 | ||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ | 595 | $ | 1,038 | ||||||||||
| Accrued liabilities | 1,438 | 1,104 | ||||||||||||
| Current portion of deferred revenues, lease liabilities, and other liabilities | 1,660 | 1,598 | ||||||||||||
| Total current liabilities | 3,693 | 3,740 | ||||||||||||
| Long-term debt | 4,440 | 4,446 | ||||||||||||
| Non-current lease liabilities | 551 | 764 | ||||||||||||
| Other non-current liabilities | 1,586 | 1,059 | ||||||||||||
| Total liabilities | 10,270 | 10,009 | ||||||||||||
| Commitments and contingencies | ||||||||||||||
| Stockholders' equity: | ||||||||||||||
Preferred stock, $0.001 par value; 10 shares authorized and 0 shares issued and outstanding as of December 31, 2025 and September 30, 2026 | — | — | ||||||||||||
Common stock, $0.001 par value; 5,258 and 5,258 shares authorized and 1,240 and 1,460 shares issued and outstanding as of December 31, 2025 and September 30, 2026, respectively | 1 | 1 | ||||||||||||
| Additional paid-in capital | 31,508 | 34,806 | ||||||||||||
| Accumulated deficit | (26,951) | (29,113) | ||||||||||||
| Accumulated other comprehensive income (loss) | 8 | (3) | ||||||||||||
| Noncontrolling interest | 28 | 27 | ||||||||||||
| Total stockholders' equity | 4,594 | 5,718 | ||||||||||||
| Total liabilities and stockholders' equity | $ | 14,864 | $ | 15,727 | ||||||||||
1 The prior period has been recast to conform to current period presentation. | ||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||
(in millions, except per share amounts) | ||||||||||||||
(unaudited) | ||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2025 | 2026 | 2025 | 2026 | |||||||||||||||||||||||
| Automotive | $ | 1,142 | $ | 1,550 | $ | 2,991 | $ | 3,601 | ||||||||||||||||||
| Software and services | 416 | 605 | 1,110 | 1,593 | ||||||||||||||||||||||
| Total revenues | 1,558 | 2,155 | 4,101 | 5,194 | ||||||||||||||||||||||
| Automotive | 1,272 | 1,630 | 3,364 | 3,779 | ||||||||||||||||||||||
| Software and services | 262 | 349 | 713 | 941 | ||||||||||||||||||||||
| Total cost of revenues | 1,534 | 1,979 | 4,077 | 4,720 | ||||||||||||||||||||||
| Gross profit | 24 | 176 | 24 | 474 | ||||||||||||||||||||||
| Operating expenses | ||||||||||||||||||||||||||
| Research and development | 453 | 485 | 1,244 | 1,409 | ||||||||||||||||||||||
| Selling, general, and administrative | 554 | 572 | 1,532 | 1,663 | ||||||||||||||||||||||
| Total operating expenses | 1,007 | 1,057 | 2,776 | 3,072 | ||||||||||||||||||||||
| Loss from operations | (983) | (881) | (2,752) | (2,598) | ||||||||||||||||||||||
| Interest income | 76 | 55 | 229 | 153 | ||||||||||||||||||||||
| Interest expense | (69) | (74) | (210) | (207) | ||||||||||||||||||||||
Other (expense) income, net1 | (191) | (8) | (86) | 488 | ||||||||||||||||||||||
| Loss before income taxes | (1,167) | (908) | (2,819) | (2,164) | ||||||||||||||||||||||
| Provision for income taxes | 1 | 1 | (3) | 4 | ||||||||||||||||||||||
| Net loss | (1,166) | (907) | (2,822) | (2,160) | ||||||||||||||||||||||
| Less: Net income attributable to noncontrolling interest | 7 | 6 | 13 | 2 | ||||||||||||||||||||||
| Net loss attributable to common stockholders | $ | (1,173) | $ | (913) | $ | (2,835) | $ | (2,162) | ||||||||||||||||||
| Net loss attributable to common stockholders, basic and diluted | $ | (1,173) | $ | (913) | $ | (2,835) | $ | (2,162) | ||||||||||||||||||
| Net loss per share attributable to Class A and Class B common stockholders, basic and diluted | $ | (0.96) | $ | (0.63) | $ | (2.42) | $ | (1.61) | ||||||||||||||||||
| Weighted-average common shares outstanding, basic and diluted | 1,220 | 1,446 | 1,171 | 1,341 | ||||||||||||||||||||||
1 During the nine months ended September 30, 2026, we recognized a $506 million gain in "Other (expense) income, net" related to the Series A capital raise and related deconsolidation of Mind Robotics. | ||||||||||||||||||||||||||
Condensed Consolidated Statements of Cash Flows1 | ||||||||||||||
(in millions) | ||||||||||||||
(unaudited) | ||||||||||||||
| Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2026 | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net loss | $ | (2,822) | $ | (2,160) | ||||||||||
| Depreciation and amortization | 583 | 682 | ||||||||||||
| Stock-based compensation expense | 551 | 634 | ||||||||||||
| Gain on strategic investments | (101) | (506) | ||||||||||||
| Other non-cash activities | (6) | 89 | ||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||
| Accounts receivable, net | 267 | (44) | ||||||||||||
| Inventory | 511 | (372) | ||||||||||||
| Other assets | (26) | 144 | ||||||||||||
| Accounts payable and accrued liabilities | 488 | 268 | ||||||||||||
| Deferred revenues | 495 | (637) | ||||||||||||
| Other liabilities | (38) | (46) | ||||||||||||
| Net cash used in operating activities | (98) | (1,948) | ||||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Purchases of short-term investments and shares for deferred compensation | (2,571) | (2,045) | ||||||||||||
| Sales of short-term investments and shares for deferred compensation | 107 | 32 | ||||||||||||
| Maturities of short-term investments | 2,204 | 2,463 | ||||||||||||
| Deconsolidation of Mind Robotics, Inc. | — | (114) | ||||||||||||
| Capital expenditures | (1,247) | (1,100) | ||||||||||||
| Net cash used in investing activities | (1,507) | (764) | ||||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Proceeds from stock-based compensation programs | $ | 34 | $ | 40 | ||||||||||
| Proceeds from issuance of capital stock | 750 | 2,617 | ||||||||||||
| Proceeds from issuance of long-term debt | 1,250 | — | ||||||||||||
| Repayments of long-term debt | (1,250) | — | ||||||||||||
| Other financing activities | (37) | (11) | ||||||||||||
| Net cash provided by financing activities | 747 | 2,646 | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 5 | (4) | ||||||||||||
| Net change in cash | (853) | (70) | ||||||||||||
| Cash and cash equivalents, and restricted cash - Beginning of period | 5,294 | 3,579 | ||||||||||||
| Cash and cash equivalents, and restricted cash - End of period | $ | 4,441 | $ | 3,509 | ||||||||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||||||||||||
| Capital expenditures included in liabilities | $ | 499 | $ | 386 | ||||||||||
| Capital stock issued to settle bonuses | $ | 47 | $ | 110 | ||||||||||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ | 224 | $ | 302 | ||||||||||
1 The prior period has been recast to conform to current period presentation. | ||||||||||||||
| Reconciliation of Non-GAAP | ||||||||||||||
| Financial Measures | ||||||||||||||
(in millions) | ||||||||||||||
(unaudited) | ||||||||||||||
| Three Months Ended | ||||||||||||||||||||||||||||||||
| September 30, 2025 | December 31, 2025 | March 31, 2026 | June 30, 2026 | September 30, 2026 | ||||||||||||||||||||||||||||
| Adjusted Research and Development Expenses | ||||||||||||||||||||||||||||||||
| Total research and development expenses | $ | 453 | $ | 424 | $ | 458 | $ | 466 | $ | 485 | ||||||||||||||||||||||
| R&D depreciation and amortization expenses | (18) | (20) | (23) | (25) | (24) | |||||||||||||||||||||||||||
| R&D stock-based compensation expenses | (74) | (76) | (87) | (94) | (79) | |||||||||||||||||||||||||||
| Adjusted research and development (non-GAAP) | $ | 361 | $ | 328 | $ | 348 | $ | 347 | $ | 382 | ||||||||||||||||||||||
| Adjusted Selling, General, and Administrative Expenses | ||||||||||||||||||||||||||||||||
| Total selling, general, and administrative expenses | $ | 554 | $ | 529 | $ | 542 | $ | 549 | $ | 572 | ||||||||||||||||||||||
| SG&A depreciation and amortization expenses | (55) | (59) | (57) | (64) | (61) | |||||||||||||||||||||||||||
| SG&A stock-based compensation expenses | (77) | (86) | (93) | (101) | (94) | |||||||||||||||||||||||||||
| Adjusted selling, general, and administrative (non-GAAP) | $ | 422 | $ | 384 | $ | 392 | $ | 384 | $ | 417 | ||||||||||||||||||||||
| Adjusted Operating Expenses | ||||||||||||||||||||||||||||||||
| Total operating expenses | $ | 1,007 | $ | 953 | $ | 1,000 | $ | 1,015 | $ | 1,057 | ||||||||||||||||||||||
| R&D depreciation and amortization expenses | (18) | (20) | (23) | (25) | (24) | |||||||||||||||||||||||||||
| R&D stock-based compensation expenses | (74) | (76) | (87) | (94) | (79) | |||||||||||||||||||||||||||
| SG&A depreciation and amortization expenses | (55) | (59) | (57) | (64) | (61) | |||||||||||||||||||||||||||
| SG&A stock-based compensation expenses | (77) | (86) | (93) | (101) | (94) | |||||||||||||||||||||||||||
| Total adjusted operating expenses (non-GAAP) | $ | 783 | $ | 712 | $ | 740 | $ | 731 | $ | 799 | ||||||||||||||||||||||
| Adjusted EBITDA | ||||||||||||||||||||||||||||||||
| Net loss attributable to common stockholders | $ | (1,173) | $ | (811) | $ | (416) | $ | (833) | $ | (913) | ||||||||||||||||||||||
| Interest (income) expense, net | (7) | — | 15 | 20 | 19 | |||||||||||||||||||||||||||
| Provision for income taxes | (1) | 3 | (2) | (1) | (1) | |||||||||||||||||||||||||||
| Depreciation and amortization | 198 | 187 | 202 | 227 | 251 | |||||||||||||||||||||||||||
| Stock-based compensation expense | 175 | 188 | 207 | 226 | 201 | |||||||||||||||||||||||||||
| Other expense (income), net¹ | 191 | (32) | (478) | (18) | 8 | |||||||||||||||||||||||||||
| Restructuring expenses | 15 | — | — | — | — | |||||||||||||||||||||||||||
| Adjusted EBITDA (non-GAAP) | $ | (602) | $ | (465) | $ | (472) | $ | (379) | $ | (435) | ||||||||||||||||||||||
1 During the nine months ended September 30, 2026, we recognized a $506 million gain in "Other (expense) income, net" on the Condensed Consolidated Statements of Operations related to the Series A capital raise and related deconsolidation of Mind Robotics. | ||||||||||||||||||||||||||||||||
| Quarterly Financial Performance | ||||||||||||||
| Reconciliation of Non-GAAP | ||||||||||||||
| Financial Measures Continued | ||||||||||||||
| (in millions, except per share amounts) | ||||||||||||||
(unaudited) | ||||||||||||||
| Three Months Ended | |||||||||||||||||||||||||||||||||||
| September 30, 2025 | December 31, 2025 | March 31, 2026 | June 30, 2026 | September 30, 2026 | |||||||||||||||||||||||||||||||
| Adjusted Net Loss | |||||||||||||||||||||||||||||||||||
| Net loss attributable to common stockholders, basic and diluted | $ | (1,173) | $ | (811) | $ | (416) | $ | (833) | $ | (913) | |||||||||||||||||||||||||
| Stock-based compensation expense | 175 | 188 | 207 | 226 | 201 | ||||||||||||||||||||||||||||||
| Other expense (income), net¹ | 191 | (32) | (478) | (18) | 8 | ||||||||||||||||||||||||||||||
| Restructuring expenses | 15 | — | — | — | — | ||||||||||||||||||||||||||||||
| Adjusted net loss attributable to common stockholders, basic and diluted (non-GAAP) | $ | (792) | $ | (655) | $ | (687) | $ | (625) | $ | (704) | |||||||||||||||||||||||||
| Adjusted Net Loss Per Share | |||||||||||||||||||||||||||||||||||
| Net loss per share attributable to common stockholders, basic and diluted | $ | (0.96) | $ | (0.66) | $ | (0.33) | $ | (0.63) | $ | (0.63) | |||||||||||||||||||||||||
| Stock-based compensation expense per share | 0.14 | 0.15 | 0.17 | 0.17 | 0.14 | ||||||||||||||||||||||||||||||
| Other expense (income), net per share¹ | 0.16 | (0.03) | (0.38) | (0.01) | 0.01 | ||||||||||||||||||||||||||||||
| Restructuring expenses per share | 0.01 | — | — | — | — | ||||||||||||||||||||||||||||||
| Adjusted net loss per share attributable to common stockholders, basic and diluted (non-GAAP) | $ | (0.65) | $ | (0.54) | * | $ | (0.54) | * | $ | (0.47) | $ | (0.48) | * | ||||||||||||||||||||||
| Weighted-average common shares outstanding, basic and diluted (GAAP) | 1,220 | 1,233 | 1,249 | 1,325 | 1,446 | ||||||||||||||||||||||||||||||
| * Does not calculate due to rounding. | |||||||||||||||||||||||||||||||||||
| Free Cash Flow | |||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) operating activities | $ | 26 | $ | (681) | $ | (703) | $ | (487) | $ | (758) | |||||||||||||||||||||||||
| Capital expenditures | (447) | (463) | (372) | (362) | (366) | ||||||||||||||||||||||||||||||
| Free cash flow (non-GAAP) | $ | (421) | $ | (1,144) | $ | (1,075) | $ | (849) | $ | (1,124) | |||||||||||||||||||||||||
1 During the nine months ended September 30, 2026, we recognized a $506 million gain in "Other (expense) income, net" on the Condensed Consolidated Statements of Operations related to the Series A capital raise and related deconsolidation of Mind Robotics. | |||||||||||||||||||||||||||||||||||